-
公开(公告)号:US20160317458A1
公开(公告)日:2016-11-03
申请号:US15104723
申请日:2014-12-17
申请人: Luis Brito , Delai Chen , Gabriel Grant Gamber , Andrew Geall , Kevin Love , Thomas Zabawa , Frederic Zecri
发明人: Luis Brito , Delai Chen , Gabriel Grant Gamber , Andrew Geall , Kevin Love , Thomas Zabawa , Frederic Zecri
IPC分类号: A61K9/51 , C07C219/06 , C07D211/62 , C07C229/12 , C07C323/52 , C07C235/08 , C07D211/06 , C07D295/13 , C07D211/22 , C07D207/16 , C07D319/06 , C07D207/12 , C07D211/46 , C07D233/64 , A61K9/127 , A61K38/22 , A61K38/18 , A61K39/12 , C12N7/00 , C12N15/113
CPC分类号: A61K9/5123 , A61K9/1272 , A61K31/7105 , A61K31/713 , A61K38/1816 , A61K38/2264 , A61K39/12 , A61K47/18 , A61K2039/53 , C07C219/06 , C07C219/16 , C07C229/12 , C07C235/08 , C07C323/52 , C07D207/12 , C07D207/16 , C07D211/06 , C07D211/22 , C07D211/46 , C07D211/62 , C07D233/60 , C07D233/64 , C07D295/088 , C07D295/13 , C07D319/06 , C12N7/00 , C12N15/1137 , C12N15/88 , C12N2310/14 , C12N2320/32 , C12N2760/00034 , C12N2760/00071
摘要: This invention provides for a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1-R3, n, p, L1 and L2 are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.
-
公开(公告)号:US10059655B2
公开(公告)日:2018-08-28
申请号:US15104736
申请日:2014-12-17
申请人: Luis Brito , Delai Chen , Gabriel Grant Gamber , Andrew Geall , Kevin Love , Thomas Zabawa , Frederic Zecri
发明人: Luis Brito , Delai Chen , Gabriel Grant Gamber , Andrew Geall , Kevin Love , Thomas Zabawa , Frederic Zecri
IPC分类号: C07C229/12 , C07C229/38 , C07D205/04 , C07D265/30 , C07D207/12 , C07D207/16 , C07D211/22 , C07D295/088 , C07D211/46 , C07D211/60 , C07D211/62 , C07D295/15 , C07C271/20 , C07C219/04 , A61K47/18 , A61K9/127 , A61K9/51 , A61K31/7105 , A61K31/713 , A61K39/39 , C07C271/22 , C07D211/06 , C07D211/34 , C07D211/44
CPC分类号: C07C229/12 , A61K9/1272 , A61K9/5123 , A61K31/7105 , A61K31/713 , A61K39/12 , A61K39/39 , A61K47/18 , A61K2039/53 , A61K2039/55555 , C07C219/04 , C07C229/38 , C07C271/20 , C07C271/22 , C07D205/04 , C07D207/12 , C07D207/16 , C07D211/06 , C07D211/22 , C07D211/34 , C07D211/44 , C07D211/46 , C07D211/60 , C07D211/62 , C07D265/30 , C07D295/088 , C07D295/15 , C12N2760/18534
摘要: This invention provides for a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1-R4, n and p are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.
-
3.
公开(公告)号:US20160311759A1
公开(公告)日:2016-10-27
申请号:US15104736
申请日:2014-12-17
申请人: Luis Brito , Delai Chen , Gabriel Grant Gamber , Andrew Geall , Kevin Love , Thomas Zabawa , Frederic Zecri
发明人: Luis Brito , Delai Chen , Gabriel Grant Gamber , Andrew Geall , Kevin Love , Thomas Zabawa , Frederic Zecri
IPC分类号: C07C229/12 , C07D295/15 , C07D211/06 , C07D211/62 , C07C271/22 , C07D211/34 , C07D265/30 , C07C229/38 , C07D211/44 , C07D205/04 , A61K9/51 , A61K9/127 , A61K31/713 , A61K39/39 , C07D207/16
CPC分类号: C07C229/12 , A61K9/1272 , A61K9/5123 , A61K31/7105 , A61K31/713 , A61K39/39 , A61K47/18 , C07C219/04 , C07C229/38 , C07C271/20 , C07C271/22 , C07D205/04 , C07D207/12 , C07D207/16 , C07D211/06 , C07D211/22 , C07D211/34 , C07D211/44 , C07D211/46 , C07D211/60 , C07D211/62 , C07D265/30 , C07D295/088 , C07D295/15
摘要: This invention provides for a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1-R4, n and p are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.
-
公开(公告)号:US10125092B2
公开(公告)日:2018-11-13
申请号:US15505282
申请日:2015-09-04
申请人: Rohan Eric John Beckwith , Luis Brito , Brian Addison Dechristopher , Gabriel Grant Gamber , Andrew Geall , Thomas Zabawa
发明人: Rohan Eric John Beckwith , Luis Brito , Brian Addison Dechristopher , Gabriel Grant Gamber , Andrew Geall , Thomas Zabawa
IPC分类号: A61K9/127 , A61K48/00 , C12N15/85 , C07K14/535 , C07C219/06 , A61K47/18 , A61K47/22 , A61K9/51 , A61K31/7105 , A61K31/711 , A61K31/713 , C07C229/12 , C07D211/62 , C07C219/16 , C07D211/34 , C07D295/15 , C07C217/58 , C07D207/08
摘要: This invention provides for a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein RA, RB, R2 and R4 are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.
-
公开(公告)号:US09636410B2
公开(公告)日:2017-05-02
申请号:US14130886
申请日:2012-07-06
申请人: Luis Brito , Michelle Chan , Andrew Geall , Derek O'Hagan , Manmohan Singh
发明人: Luis Brito , Michelle Chan , Andrew Geall , Derek O'Hagan , Manmohan Singh
CPC分类号: A61K39/39 , A61K9/1075 , A61K39/12 , A61K39/155 , A61K39/245 , A61K47/02 , A61K47/06 , A61K47/12 , A61K47/22 , A61K47/24 , A61K47/26 , A61K47/34 , A61K2039/5256 , A61K2039/53 , A61K2039/55555 , A61K2039/55566 , A61K2039/575 , C12N7/00 , C12N2710/16134 , C12N2710/16171 , C12N2710/16734 , C12N2710/16771 , C12N2760/18534 , C12N2760/18571 , C12N2770/36134 , C12N2770/36143 , C12N2840/203 , Y02A50/386 , Y02A50/388 , Y02A50/412
摘要: This invention generally relates to cationic oil-in-water emulsions that contain high concentrations of cationic lipids and have a defined oil:lipid ratio. The cationic lipid can interact with the negatively charged molecule thereby anchoring the molecule to the emulsion particles. The cationic emulsions described herein are useful for delivering negatively charged molecules, such as nucleic acid molecules to cells, and for formulating nucleic acid-based vaccines.
-
公开(公告)号:US09655845B2
公开(公告)日:2017-05-23
申请号:US14130880
申请日:2012-07-06
申请人: Luis Brito , Michelle Chan , Andrew Geall , Derek O'Hagan , Manmohan Singh
发明人: Luis Brito , Michelle Chan , Andrew Geall , Derek O'Hagan , Manmohan Singh
IPC分类号: A61K9/107 , A61K31/713 , A61K39/155 , A61K39/12 , A61K9/00 , A61K39/00
CPC分类号: A61K9/107 , A61K9/0019 , A61K31/713 , A61K39/12 , A61K39/155 , A61K2039/53 , A61K2039/55566 , C12N2760/18534 , Y02A50/412
摘要: This invention generally relates to cationic oil-in-water emulsions that can be used to deliver nucleic acid molecules, such as an RNA molecule. The emulsion particles comprise an oil core and a cationic lipid. The emulsion particles have an average diameter of about 80 nm to about 180 nm, and the emulsion have an N/P ratio of at least 1.1:1.
-
公开(公告)号:US09295646B2
公开(公告)日:2016-03-29
申请号:US13235454
申请日:2011-09-18
申请人: Luis Brito , Andrew Geall , Derek O'Hagan , Manmohan Singh
发明人: Luis Brito , Andrew Geall , Derek O'Hagan , Manmohan Singh
CPC分类号: A61K39/385 , A61K9/107 , A61K39/39 , A61K2039/53 , A61K2039/55566
摘要: This invention generally relates to cationic oil-in-water emulsions that can be used to deliver negatively charged molecules, such as an RNA molecule. The emulsion particles comprise an oil core and a cationic lipid. The cationic lipid can interact with the negatively charged molecule thereby anchoring the molecule to the emulsion particles. The cationic emulsions described herein are particularly suitable for delivering nucleic acid molecules (such as an RNA molecule encoding an antigen) to cells and formulating nucleic acid-based vaccines.
摘要翻译: 本发明一般涉及阳离子水包油乳液,其可用于递送带负电荷的分子,例如RNA分子。 乳剂颗粒包含油芯和阳离子脂质。 阳离子脂质可以与带负电荷的分子相互作用,从而将分子固定在乳液颗粒上。 本文所述的阳离子乳剂特别适用于将核酸分子(例如编码抗原的RNA分子)递送至细胞并配制基于核酸的疫苗。
-
公开(公告)号:US20140220083A1
公开(公告)日:2014-08-07
申请号:US14130886
申请日:2012-07-06
申请人: Luis Brito , Michelle Chan , Andrew Geall , Derek O'Hagan , Manmohan Singh
发明人: Luis Brito , Michelle Chan , Andrew Geall , Derek O'Hagan , Manmohan Singh
CPC分类号: A61K39/39 , A61K9/1075 , A61K39/12 , A61K39/155 , A61K39/245 , A61K47/02 , A61K47/06 , A61K47/12 , A61K47/22 , A61K47/24 , A61K47/26 , A61K47/34 , A61K2039/5256 , A61K2039/53 , A61K2039/55555 , A61K2039/55566 , A61K2039/575 , C12N7/00 , C12N2710/16134 , C12N2710/16171 , C12N2710/16734 , C12N2710/16771 , C12N2760/18534 , C12N2760/18571 , C12N2770/36134 , C12N2770/36143 , C12N2840/203 , Y02A50/386 , Y02A50/388 , Y02A50/412
摘要: This invention generally relates to cationic oil-in-water emulsions that contain high concentrations of cationic lipids and have a defined oil:lipid ratio. The cationic lipid can interact with the negatively charged molecule thereby anchoring the molecule to the emulsion particles. The cationic emulsions described herein are useful for delivering negatively charged molecules, such as nucleic acid molecules to cells, and for formulating nucleic acid-based vaccines.
摘要翻译: 本发明一般涉及含有高浓度阳离子脂质并具有确定的油脂比例的阳离子水包油乳剂。 阳离子脂质可以与带负电荷的分子相互作用,从而将分子固定在乳液颗粒上。 本文所述的阳离子乳液可用于将带负电荷的分子(例如核酸分子)递送至细胞,以及配制基于核酸的疫苗。
-
公开(公告)号:US20140212498A1
公开(公告)日:2014-07-31
申请号:US14130880
申请日:2012-07-06
申请人: Luis Brito , Michelle Chan , Andrew Geall , Derek O'Hagan , Manmohan Singh
发明人: Luis Brito , Michelle Chan , Andrew Geall , Derek O'Hagan , Manmohan Singh
IPC分类号: A61K9/107 , A61K31/713
CPC分类号: A61K9/107 , A61K9/0019 , A61K31/713 , A61K39/12 , A61K39/155 , A61K2039/53 , A61K2039/55566 , C12N2760/18534 , Y02A50/412
摘要: This invention generally relates to cationic oil-in-water emulsions that can be used to deliver nucleic acid molecules, such as an RNA molecule. The emulsion particles comprise an oil core and a cationic lipid. The emulsion particles have an average diameter of about 80 nm to about 180 nm, and the emulsion have an N/P ratio of at least 1.1:1.
摘要翻译: 本发明一般涉及可用于递送核酸分子(例如RNA分子)的阳离子水包油乳液。 乳剂颗粒包含油芯和阳离子脂质。 乳剂颗粒的平均直径为约80nm至约180nm,乳液的N / P比至少为1.1:1。
-
公开(公告)号:US10286056B2
公开(公告)日:2019-05-14
申请号:US13982042
申请日:2012-01-27
申请人: Luis Brito , Manmohan Singh , Derek O'Hagan
发明人: Luis Brito , Manmohan Singh , Derek O'Hagan
IPC分类号: A61K39/39 , A61K39/095 , A61K9/107 , A61K31/00 , A61K31/4745 , A61K9/00 , A61K31/4375 , A61K47/26 , A61K47/32 , A61K47/44
摘要: High loading of lipophilic pharmacological agents (in particular, lipophilic immunopotentiators) in oil-in-water emulsions can result in crystallisation of the lipophilic agent. To overcome this problem the invention uses an oil-in-water emulsion in combination with a crystallisation inhibitor, and this combination provides emulsions which can be loaded with high levels of lipophilic pharmacological agents.
-
-
-
-
-
-
-
-
-